Advances in the roles of glycyrrhizic acid in cancer therapy.

anti-cancer cancer glycyrrhizic acid mechanisms side effects

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2023
Historique:
received: 22 07 2023
accepted: 07 08 2023
medline: 31 8 2023
pubmed: 31 8 2023
entrez: 31 8 2023
Statut: epublish

Résumé

Since the first 70 years of reporting cancer chemotherapy, malignant tumors have been the second most common cause of death in children and adults. Currently, the commonly used anti-cancer methods include surgery, chemotherapy, radiotherapy, and immunotherapy. Although these treatment methods could alleviate cancer, they lead to different forms of side effects and have no particularly significant effect on prolonging the patients' life span. Glycyrrhizic acid (GL), a native Chinese herbal extract, has a wide range of pharmacological effects, such as anti-cancer, anti-inflammatory, antioxidant, and immune regulation. In this review, the anti-cancer effects and mechanisms of GL are summarized in various cancers. The inhibition of GL on chemotherapy-induced side effects, including hepatotoxicity, nephrotoxicity, genotoxicity, neurotoxicity and pulmonary toxicity, is highlighted. Therefore, GL may be a promising and ideal drug for cancer therapy.

Identifiants

pubmed: 37649893
doi: 10.3389/fphar.2023.1265172
pii: 1265172
pmc: PMC10463042
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1265172

Informations de copyright

Copyright © 2023 Zhang, Sheng, Xiao, Li, Huang, Jia, Zeng and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Chin Med. 2023;51(2):391-405
pubmed: 36655685
Medicines (Basel). 2018 Nov 13;5(4):
pubmed: 30428619
J Drug Deliv. 2014;2014:670815
pubmed: 24872894
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13
pubmed: 24618998
Expert Rev Clin Pharmacol. 2023 Jan-Jun;16(6):601-611
pubmed: 37218470
Xenobiotica. 2009 Dec;39(12):955-63
pubmed: 19831503
PLoS One. 2013;8(2):e56020
pubmed: 23457494
Perspect Biol Med. 2019;62(4):778-784
pubmed: 31761807
Int J Clin Exp Pathol. 2015 May 01;8(5):5175-81
pubmed: 26191214
J Biomed Biotechnol. 2003;2003(1):25-34
pubmed: 12686720
Drug Des Devel Ther. 2018 May 18;12:1311-1319
pubmed: 29849452
Biomed Pharmacother. 2017 Nov;95:670-678
pubmed: 28886526
Anticancer Res. 2021 Dec;41(12):6231-6236
pubmed: 34848478
Int J Oncol. 2007 Dec;31(6):1465-72
pubmed: 17982673
Fitoterapia. 2021 Jun;151:104860
pubmed: 33582265
Med Sci Monit. 2019 Mar 11;25:1828-1837
pubmed: 30853709
Biomed Res Int. 2014;2014:872139
pubmed: 24963489
Molecules. 2019 Jul 04;24(13):
pubmed: 31277398
Iran J Otorhinolaryngol. 2023 Jul;35(129):189-197
pubmed: 37497164
Mol Omics. 2023 Aug 14;19(7):585-597
pubmed: 37345535
Front Oncol. 2022 Aug 03;12:819599
pubmed: 35992881
Neurol Sci. 2014 Jul;35(7):1115-20
pubmed: 24514918
Oncol Rep. 2012 Dec;28(6):2069-76
pubmed: 22972479
Eur J Pharm Biopharm. 2016 Aug;105:141-7
pubmed: 27287555
Scientifica (Cairo). 2013;2013:635203
pubmed: 24416617
Ann Neurol. 2017 Jun;81(6):772-781
pubmed: 28486769
Int J Pharm. 2020 Apr 15;579:119159
pubmed: 32081798
CJEM. 2009 Jan;11(1):94-6
pubmed: 19166646
Pharmaceuticals (Basel). 2023 Apr 23;16(5):
pubmed: 37242424
Bioengineered. 2022 Feb;13(2):2720-2731
pubmed: 34747319
Continuum (Minneap Minn). 2020 Dec;26(6):1646-1672
pubmed: 33273176
Arch Immunol Ther Exp (Warsz). 2012 Oct;60(5):391-9
pubmed: 22922889
J Gastroenterol Hepatol. 1999 Nov;14(11):1093-9
pubmed: 10574137
Planta Med. 1991 Apr;57(2):119-21
pubmed: 1891493
Anticancer Res. 2017 Mar;37(3):997-1004
pubmed: 28314257
Life Sci. 2023 Feb 1;314:121317
pubmed: 36566881
J Exp Med. 2006 Jul 10;203(7):1637-42
pubmed: 16818669
Lab Invest. 2004 Aug;84(8):941-51
pubmed: 15184909
Sci Rep. 2017 Aug 3;7(1):7222
pubmed: 28775294
Anticancer Res. 2023 Apr;43(4):1493-1501
pubmed: 36974794
Planta Med. 1984 Aug;50(4):298-302
pubmed: 6505079
Biochem Biophys Res Commun. 2007 Jun 8;357(3):620-6
pubmed: 17449014
Drug Chem Toxicol. 2015 Oct;38(4):452-9
pubmed: 25678195
ACS Chem Neurosci. 2023 Feb 15;14(4):699-708
pubmed: 36718586
Nutr Cancer. 2001;39(1):1-11
pubmed: 11588889
J Agric Food Chem. 2015 Feb 4;63(4):1200-1209
pubmed: 25588318
Expert Opin Drug Deliv. 2008 Jun;5(6):653-63
pubmed: 18532921
Xenobiotica. 2017 Apr;47(4):290-296
pubmed: 27218144
Acta Pharmacol Sin. 2015 Sep;36(9):1145-50
pubmed: 26279158
Colloids Surf B Biointerfaces. 2019 Mar 1;175:106-115
pubmed: 30529816
Cell. 2011 Apr 1;145(1):25-9
pubmed: 21458665
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Adv Pharm Bull. 2014 Oct;4(Suppl 1):421-7
pubmed: 25364657
Ann Hematol. 2017 Jul;96(7):1185-1196
pubmed: 28389687
Immunopharmacol Immunotoxicol. 2021 Aug;43(4):461-470
pubmed: 34142927
Fitoterapia. 2014 Sep;97:1-14
pubmed: 24862064
Cell Stem Cell. 2010 Sep 3;7(3):403-17
pubmed: 20804975
Biomed Res Int. 2018 Jan 15;2018:6916797
pubmed: 29568761
AAPS PharmSciTech. 2016 Jun;17(3):553-71
pubmed: 27068527
Pharmaceutics. 2021 Oct 26;13(11):
pubmed: 34834206
Front Oncol. 2020 Jan 09;9:1431
pubmed: 31998631
Nat Med. 2009 Aug;15(8):907-13
pubmed: 19648928
Am J Transl Res. 2016 Feb 15;8(2):1064-72
pubmed: 27158392
Pharmacol Toxicol. 2003 Sep;93(3):116-22
pubmed: 12969435
Hepatology. 2011 Oct;54(4):1259-72
pubmed: 21735473
J Microencapsul. 2002 Mar-Apr;19(2):225-35
pubmed: 11837977
Food Chem Toxicol. 2017 Jul;105:370-376
pubmed: 28428088
Cancer Manag Res. 2020 Apr 24;12:2853-2861
pubmed: 32425599
Int J Mol Sci. 2019 Oct 12;20(20):
pubmed: 31614879
Am J Physiol. 1992 Dec;263(6):E1125-30
pubmed: 1476186
Int J Mol Sci. 2022 Jun 29;23(13):
pubmed: 35806253
Environ Toxicol. 2018 Dec;33(12):1272-1283
pubmed: 30255981
Singapore Med J. 2014 Dec;55(12):621-8
pubmed: 25630323
Neurochem Res. 2018 Oct;43(10):1914-1926
pubmed: 30206804
J Agric Food Chem. 2019 Mar 27;67(12):3323-3332
pubmed: 30832473
Cell Physiol Biochem. 2014;33(2):375-88
pubmed: 24556579
Int J Mol Sci. 2022 Dec 09;23(24):
pubmed: 36555256
Curr Gastroenterol Rep. 2016 Jul;18(7):34
pubmed: 27184043
Theranostics. 2019 Aug 14;9(21):6239-6255
pubmed: 31534548
Toxicology. 2012 Jan 27;291(1-3):25-31
pubmed: 22051199
Int J Mol Med. 2005 Aug;16(2):233-6
pubmed: 16012754
Exp Biol Med (Maywood). 2021 Aug;246(16):1791-1801
pubmed: 33820469
J Agric Food Chem. 2009 Jan 28;57(2):754-61
pubmed: 19105645
Molecules. 2015 Mar 06;20(3):4337-56
pubmed: 25756651
Mol Med. 2023 Apr 10;29(1):51
pubmed: 37038107
Int J Pharm. 2019 Mar 25;559:271-279
pubmed: 30690130
World J Clin Oncol. 2020 Apr 24;11(4):190-204
pubmed: 32355641
Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):85-98
pubmed: 8118391
Metabolites. 2022 Nov 17;12(11):
pubmed: 36422270
Int J Mol Sci. 2021 Feb 18;22(4):
pubmed: 33670524
Expert Rev Hematol. 2015 Feb;8(1):29-41
pubmed: 25374305
Oncol Rep. 2016 Dec;36(6):3145-3153
pubmed: 27748871
Curr Pharm Des. 2023 Jun 6;29(15):1218-1229
pubmed: 37138418
Lancet. 2003 Jun 14;361(9374):2045-6
pubmed: 12814717
Mol Med Rep. 2017 May;15(5):3062-3068
pubmed: 28339089
Regul Toxicol Pharmacol. 2006 Dec;46(3):167-92
pubmed: 16884839
Neurobiol Dis. 2012 Apr;46(1):147-56
pubmed: 22266336
Cells. 2023 Apr 25;12(9):
pubmed: 37174648
Cell Cycle. 2006 Apr;5(8):812-7
pubmed: 16627996
J Nanobiotechnology. 2020 Jan 9;18(1):10
pubmed: 31918721
J Neuroinflammation. 2016 Sep 08;13(1):241
pubmed: 27609334
Int Immunopharmacol. 2020 Nov;88:106932
pubmed: 32890791
Eur J Cancer. 2016 May;59:134-141
pubmed: 27033261
Cell Physiol Biochem. 2017;41(4):1383-1392
pubmed: 28315871
Eur Rev Med Pharmacol Sci. 2017 Feb;21(4):890-899
pubmed: 28272690
Clin Exp Hypertens. 1995 Apr;17(3):575-91
pubmed: 7613529
Biomed Pharmacother. 2020 Feb;122:109354
pubmed: 31918260
Antioxidants (Basel). 2021 Nov 29;10(12):
pubmed: 34943021
Handb Clin Neurol. 2012;105:485-506
pubmed: 22230514
J Skin Cancer. 2011;2011:858425
pubmed: 22007306
Sci Rep. 2016 Jul 12;6:29680
pubmed: 27403722
Toxics. 2021 Sep 22;9(10):
pubmed: 34678925
Life Sci. 2011 Sep 26;89(13-14):422-9
pubmed: 21803049
Medchemcomm. 2018 Jul 19;9(9):1502-1510
pubmed: 30288224
Anticancer Res. 2002 Nov-Dec;22(6C):4053-8
pubmed: 12553032
Neurotoxicology. 2000 Jun;21(3):389-93
pubmed: 10894128
Hum Exp Toxicol. 2012 Dec;31(12):1295-8
pubmed: 22653692
Am J Chin Med. 2020;48(1):223-244
pubmed: 32054305
Chem Biol Interact. 2014 Sep 5;220:214-21
pubmed: 25016076

Auteurs

Yuqian Zhang (Y)

Research Center of Neuroscience, Jiaxing, China.

Zixuan Sheng (Z)

Research Center of Neuroscience, Jiaxing, China.

Jing Xiao (J)

Research Center of Neuroscience, Jiaxing, China.

Yang Li (Y)

Research Center of Neuroscience, Jiaxing, China.

Jie Huang (J)

Research Center of Neuroscience, Jiaxing, China.

Jinjing Jia (J)

Research Center of Neuroscience, Jiaxing, China.
Department of Physiology, Jiaxing, China.

Xiansi Zeng (X)

Research Center of Neuroscience, Jiaxing, China.
Department of Biochemistry and Molecular Biology, Jiaxing University Medical College, Jiaxing, China.

Li Li (L)

Research Center of Neuroscience, Jiaxing, China.
Department of Physiology, Jiaxing, China.

Classifications MeSH